DEA: Potential New Telemedicine Special Registration for Controlled Substances Prescribing to be Discussed in Special Listening Sessions

The Drug Enforcement Administration (DEA) is signaling its consideration of a separate Special Registration for telemedicine prescribing without the prerequisite of an in-person examination. On August 4, 2023, the DEA released a pre-publication Notice of Meeting, announcing plans to conduct public sessions this upcoming fall. In this article, Foley & Lardner delve into the DEA’s considerations and provide insights on the scheduled public listening sessions set for Tuesday, September 12, 2023.

  Download PDF